supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
drug:
Muromonab-Cd3
supplement:
Oligomeric Procyanidin Complex
Research Papers that Mention the Interaction
“The cytotoxicity of the clones against BCL1 and MOPC was specifically inhibited by anti-CD3 , anti-alphabetaTCR, or anti-relevant Vbeta (Vbeta8) Ab, but not by control Abs, indicating that it was mediated by the specific alphabetaTCR/CD3.”
NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback